SlideShare a Scribd company logo
PROPHYLACTICS OF
PNEUMONIA
VACCINATION
JOISY ALOOR
LEONARD SHAJU
ACCORDING TO WHO
• Pneumonia accounts for 15% of all deaths of
children under 5 years old, killing 808 694 children
in 2017.
• Pneumonia can be caused by viruses, bacteria, or
fungi.
• Pneumonia can be prevented by immunization,
adequate nutrition, and by addressing
environmental factors.
• Pneumonia caused by bacteria can be treated with
antibiotics, but only one third of children with
pneumonia receive the antibiotics they need.
EPIDEMIOLOGY
• Pneumonia is a common illness affecting
approximately 450 million people a year and
occurring in all parts of the world. It is a major cause
of death among all age groups resulting in 4 million
deaths (7% of the world's total death) yearly.
• Rates are greatest in children less than five, and
adults older than 75 years. It occurs about five times
more frequently in the developing world than in the
developed world. Viral pneumonia accounts for
about 200 million cases. In the United States, as of
2009, pneumonia is the 8th leading cause of death.
TREATMENT
• Pneumonia should be treated with antibiotics.
The antibiotic of choice is amoxicillin dispersible
tablets. Most cases of pneumonia require oral
antibiotics, which are often prescribed at a
health centre.
• These cases can also be diagnosed and treated
with inexpensive oral antibiotics at the
community level by trained community health
workers. Hospitalization is recommended only
for severe cases of pneumonia.
PREVENTION
• Preventing pneumonia in children is an essential
component of a strategy to reduce child mortality.
Immunization against Hib, pneumococcus, measles
and whooping cough (pertussis) is the most effective
way to prevent pneumonia.
• Adequate nutrition is key to improving children's
natural defenses, starting with exclusive
breastfeeding for the first 6 months of life. In
addition to being effective in preventing pneumonia,
it also helps to reduce the length of the illness if a
child does become ill.
• Addressing environmental factors such as
indoor air pollution (by providing affordable
clean indoor stoves, for example) and
encouraging good hygiene in crowded homes
also reduces the number of children who fall ill
with pneumonia.
• In children infected with HIV, the antibiotic
cotrimoxazole is given daily to decrease the risk
of contracting pneumonia.
PREVENTION BY WHO
The WHO and UNICEF integrated Global action
plan for pneumonia and diarrhoea (GAPPD)
aims to accelerate pneumonia control with a
combination of interventions to protect, prevent,
and treat pneumonia in children with actions to:
• Protect children from pneumonia including
promoting exclusive breastfeeding and adequate
complementary feeding;
• Prevent pneumonia with vaccinations, hand
washing with soap, reducing household air
pollution, HIV prevention and cotrimoxazole
prophylaxis for HIV-infected and exposed children.
• Treat pneumonia focusing on making sure that
every sick child has access to the right kind of care --
either from a community-based health worker, or in
a health facility if the disease is severe -- and can get
the antibiotics and oxygen they need to get well.
• A number of countries including Bangladesh,
India, Kenya, Uganda and Zambia have
developed district, state and national plans to
intensify actions for the control of pneumonia.
• Many more have integrated pneumonia specific
action into their national child health and child
survival strategies. For many countries the post
Millenium Development Goal agenda has
explicitly included ending pneumonia deaths as
a priority action.
• Prevention includes vaccination, environmental
measures and appropriate treatment of other
health problems.[19] It is believed that, if
appropriate preventive measures were instituted
globally, mortality among children could be
reduced by 400,000; and, if proper treatment
were universally available, childhood deaths
could be decreased by another 600,000.
VACCINATION
• Vaccination prevents against certain bacterial
and viral pneumonias both in children and
adults. Influenza vaccines are modestly effective
at preventing symptoms of influenza.
• The Center for Disease Control and Prevention
(CDC) recommends yearly influenza vaccination
for every person 6 months and older.
Immunizing health care workers decreases the
risk of viral pneumonia among their people.
• Vaccinations against Haemophilus influenzae
and Streptococcus pneumoniae have good
evidence to support their use. There is strong
evidence for vaccinating children under the age
of 2 against Streptococcus pneumoniae
(pneumococcal conjugate vaccine).
• Vaccinating children against Streptococcus
pneumoniae has led to a decreased rate of these
infections in adults, because many adults
acquire infections from children.
PCV13
• The pneumococcal conjugate vaccine prevents
against 13 kinds of bacteria that cause serious
infections in children and adults.
• PCV13 is part of the standard vaccination
protocol for babies and is administered by a
pediatrician.
• In babies, it’s given as a three- or four-dose series,
beginning when they’re 2 months old. The final dose is
given to babies by 15 months.
• In adults aged 65 and older, PCV13 is given as a one-time
injection. Your doctor may recommend revaccination in
5 to 10 years.
PPSV23
• Pneumococcal polysaccharide vaccine is a one-
dose vaccine that protects against 23 kinds of
bacteria. It’s not recommended for children.
• PPSV23 is recommended for adults over age 65
who’ve already received the PCV13 vaccine. This
typically occurs around one year later.
• People aged 19 to 64 who smoke or have
conditions that increase their risk for
pneumonia should also get this vaccine.
• People who receive PPSV23 at age 65 generally
don’t require revaccination at a later date.
• The pneumococcal vaccine has been shown to
reduce the risk of community acquired pneumonia
in people with chronic obstructive pulmonary
disease, but does not reduce mortality or the risk of
hospitalization for people with this condition.
• People with COPD are suggested to have a
pneumococcal vaccination. Other vaccines for which
there is support for a protective effect against
pneumonia include pertussis, varicella, and measles.
• Certain people should not get the pneumonia
vaccine. They include:
• people who are allergic to the vaccine or any
ingredient in it
• people who had an allergic reaction to PCV7, a
former version of the pneumonia vaccine
• women who are pregnant
• people who have a severe cold, flu, or other
illness
• Both pneumonia vaccines may have some side
effects. These may include:
• redness or swelling at the injection site
• muscle aches
• fever
• chills
• living in a hospice or institutionalized setting
• using a ventilator
• frequent hospitalizations
• a weakened immune system
• a progressive lung disease, such as COPD
• asthma
• heart disease
• smoking cigarettes
• People at risk for aspiration pneumonia include
those who:
• overuse alcohol or recreational drugs
• have medical issues affecting their gag reflex,
such as a brain injury or trouble swallowing
• are recovering from surgical procedures that
required anesthesia
• Tips for avoiding postoperative pneumonia
(pneumonia after surgery) include:
• deep breathing and coughing exercises, which
your doctor or nurse will walk you through
• keeping your hands clean
• keeping your head elevated
• oral hygiene, which includes an antiseptic such
as chlorhexidine
• sitting as much as possible, and walking as soon
as you are able
OTHERS
• Smoking cessation and reducing indoor air
pollution, such as that from cooking indoors
with wood or dung, are both recommended.
Smoking appears to be the single biggest risk
factor for pneumococcal pneumonia in
otherwise-healthy adults.
• Hand hygiene and coughing into one's sleeve
may also be effective preventative measures.
Wearing surgical masks by the sick may also
prevent illness.
• Appropriately treating underlying illnesses (such
as HIV/AIDS, diabetes mellitus, and
malnutrition) can decrease the risk of
pneumonia.
• In children less than 6 months of age, exclusive
breast feeding reduces both the risk and severity
of disease.
• Testing pregnant women for Group B
Streptococcus and Chlamydia trachomatis, and
administering antibiotic treatment, if needed,
reduces rates of pneumonia in infants.
• Zinc supplementation in children 2 months to
five years old appears to reduce rates of
pneumonia.
THANK YOU
TAKE CARE : )

More Related Content

What's hot

8 Major Risk Factors for Covid-19 Infection
8 Major Risk Factors for Covid-19 Infection8 Major Risk Factors for Covid-19 Infection
8 Major Risk Factors for Covid-19 Infection
Dr Satish Pandav
 
Epidemiology of Tuberculosis
Epidemiology of TuberculosisEpidemiology of Tuberculosis
Epidemiology of Tuberculosis
saheli chakraborty
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
Arifa T N
 
Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia
NITISH SHAH
 
Community acquired pneumonia in children
Community acquired pneumonia in childrenCommunity acquired pneumonia in children
Community acquired pneumonia in children
Khaled Saad
 
Pneumonia, paediatric perspective
Pneumonia, paediatric perspectivePneumonia, paediatric perspective
Pneumonia, paediatric perspective
Dhan Shrestha
 
Community acquired pneumonia in children (1)
Community acquired pneumonia in children (1)Community acquired pneumonia in children (1)
Community acquired pneumonia in children (1)
Dr. Saad Saleh Al Ani
 
Flu awareness
Flu awareness Flu awareness
Flu awareness
GabrielBon1
 
Childhood tuberculosis & Revised RNTCP guidelines
Childhood tuberculosis & Revised RNTCP guidelinesChildhood tuberculosis & Revised RNTCP guidelines
Childhood tuberculosis & Revised RNTCP guidelines
Saurav Upadhyay
 
School Health Programmes During COVID-19
School Health Programmes During COVID-19 School Health Programmes During COVID-19
School Health Programmes During COVID-19
Aakanksha Dua
 
Basic introduction communicable
Basic introduction communicableBasic introduction communicable
Basic introduction communicable
Abdiwali Abdullahi Abdiwali
 
Tuberculosis at glance
Tuberculosis at glanceTuberculosis at glance
Tuberculosis at glance
Rehab India Foundation
 
tuberculosis in children-Hamisi Mkindi
tuberculosis in children-Hamisi Mkindituberculosis in children-Hamisi Mkindi
tuberculosis in children-Hamisi Mkindi
Mkindi Mkindi
 
Airborne diseases
Airborne diseasesAirborne diseases
Airborne diseases
Dr.Vishwajeet Chavan
 
COVID 19 AWARENESS
COVID 19 AWARENESSCOVID 19 AWARENESS
COVID 19 AWARENESS
JoyMaeBaingan1
 
Dengue Fever Information
Dengue Fever InformationDengue Fever Information
Dengue Fever Information
Rainbow Hospital
 
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
MaryRoseHughesRicero
 
Covid 19
Covid 19Covid 19
Covid 19
Alataph Mulla
 
Tuberculosis in pediatric age group
Tuberculosis in pediatric age groupTuberculosis in pediatric age group
Tuberculosis in pediatric age group
محمد التميمي
 
Control of communicable diseases
Control of communicable diseases Control of communicable diseases
Control of communicable diseases
Rozelle Mae Birador
 

What's hot (20)

8 Major Risk Factors for Covid-19 Infection
8 Major Risk Factors for Covid-19 Infection8 Major Risk Factors for Covid-19 Infection
8 Major Risk Factors for Covid-19 Infection
 
Epidemiology of Tuberculosis
Epidemiology of TuberculosisEpidemiology of Tuberculosis
Epidemiology of Tuberculosis
 
Pulmonary tuberculosis
Pulmonary tuberculosisPulmonary tuberculosis
Pulmonary tuberculosis
 
Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia
 
Community acquired pneumonia in children
Community acquired pneumonia in childrenCommunity acquired pneumonia in children
Community acquired pneumonia in children
 
Pneumonia, paediatric perspective
Pneumonia, paediatric perspectivePneumonia, paediatric perspective
Pneumonia, paediatric perspective
 
Community acquired pneumonia in children (1)
Community acquired pneumonia in children (1)Community acquired pneumonia in children (1)
Community acquired pneumonia in children (1)
 
Flu awareness
Flu awareness Flu awareness
Flu awareness
 
Childhood tuberculosis & Revised RNTCP guidelines
Childhood tuberculosis & Revised RNTCP guidelinesChildhood tuberculosis & Revised RNTCP guidelines
Childhood tuberculosis & Revised RNTCP guidelines
 
School Health Programmes During COVID-19
School Health Programmes During COVID-19 School Health Programmes During COVID-19
School Health Programmes During COVID-19
 
Basic introduction communicable
Basic introduction communicableBasic introduction communicable
Basic introduction communicable
 
Tuberculosis at glance
Tuberculosis at glanceTuberculosis at glance
Tuberculosis at glance
 
tuberculosis in children-Hamisi Mkindi
tuberculosis in children-Hamisi Mkindituberculosis in children-Hamisi Mkindi
tuberculosis in children-Hamisi Mkindi
 
Airborne diseases
Airborne diseasesAirborne diseases
Airborne diseases
 
COVID 19 AWARENESS
COVID 19 AWARENESSCOVID 19 AWARENESS
COVID 19 AWARENESS
 
Dengue Fever Information
Dengue Fever InformationDengue Fever Information
Dengue Fever Information
 
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
"Un-Crowning" the Corona, Facts and Myths about COVID 19 Busted!
 
Covid 19
Covid 19Covid 19
Covid 19
 
Tuberculosis in pediatric age group
Tuberculosis in pediatric age groupTuberculosis in pediatric age group
Tuberculosis in pediatric age group
 
Control of communicable diseases
Control of communicable diseases Control of communicable diseases
Control of communicable diseases
 

Similar to Prophylactics of Pneumonia

The integrated Global Action Plan for the Prevention and Control of Pneumonia...
The integrated Global Action Plan for the Prevention and Control of Pneumonia...The integrated Global Action Plan for the Prevention and Control of Pneumonia...
The integrated Global Action Plan for the Prevention and Control of Pneumonia...
Preston Healthcare Consulting
 
Acute Bronchiolitis.pptx
Acute Bronchiolitis.pptxAcute Bronchiolitis.pptx
Acute Bronchiolitis.pptx
Efosa Aimien
 
tuberculosis epidemiology
tuberculosis epidemiologytuberculosis epidemiology
tuberculosis epidemiology
Swasthavritta Akhandanad
 
Antibacterial therapy in COVID-19 patients - an evidence based guideline
Antibacterial therapy in COVID-19  patients - an evidence based guidelineAntibacterial therapy in COVID-19  patients - an evidence based guideline
Antibacterial therapy in COVID-19 patients - an evidence based guideline
Dr Jay Prakash
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
JenEugenio2
 
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
martinshaji
 
lrd-200923144733.pdf
lrd-200923144733.pdflrd-200923144733.pdf
lrd-200923144733.pdf
Naomikibithe
 
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxWORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
anjalatchi
 
Vaccine preventable diseases
Vaccine preventable diseasesVaccine preventable diseases
Vaccine preventable diseases
Namita Batra
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
JenEugenio2
 
ROJOSON-PEP-TALK: Safety Program Against COVID19 (May 15, 2021)
ROJOSON-PEP-TALK: Safety Program Against COVID19 (May 15, 2021)ROJOSON-PEP-TALK: Safety Program Against COVID19 (May 15, 2021)
ROJOSON-PEP-TALK: Safety Program Against COVID19 (May 15, 2021)
Reynaldo Joson
 
Flu Vaccine
Flu VaccineFlu Vaccine
Flu Vaccine
Vivek Varat
 
Influenza - History, Vaccination, and Public Health
Influenza - History, Vaccination, and Public HealthInfluenza - History, Vaccination, and Public Health
Influenza - History, Vaccination, and Public Health
Louise O' Flynn
 
Pneumonia in children
Pneumonia in children Pneumonia in children
Pneumonia in children
Azad Haleem
 
Pneumonia
PneumoniaPneumonia
The national flu immunisation programme 2017/18 - training for professionals
The national flu immunisation programme 2017/18 - training for professionalsThe national flu immunisation programme 2017/18 - training for professionals
The national flu immunisation programme 2017/18 - training for professionals
Public Health England
 
Pneumonia and its causes sign symptome treatment
Pneumonia and its causes sign symptome treatmentPneumonia and its causes sign symptome treatment
Pneumonia and its causes sign symptome treatment
wajidullah9551
 
Pneumonia in children
Pneumonia in childrenPneumonia in children
Pneumonia in children
Thorsang Chayovan
 
Corona
CoronaCorona
Epidemiology of tuberculosis... 98754328
Epidemiology of tuberculosis... 98754328Epidemiology of tuberculosis... 98754328
Epidemiology of tuberculosis... 98754328
MadhuSM4
 

Similar to Prophylactics of Pneumonia (20)

The integrated Global Action Plan for the Prevention and Control of Pneumonia...
The integrated Global Action Plan for the Prevention and Control of Pneumonia...The integrated Global Action Plan for the Prevention and Control of Pneumonia...
The integrated Global Action Plan for the Prevention and Control of Pneumonia...
 
Acute Bronchiolitis.pptx
Acute Bronchiolitis.pptxAcute Bronchiolitis.pptx
Acute Bronchiolitis.pptx
 
tuberculosis epidemiology
tuberculosis epidemiologytuberculosis epidemiology
tuberculosis epidemiology
 
Antibacterial therapy in COVID-19 patients - an evidence based guideline
Antibacterial therapy in COVID-19  patients - an evidence based guidelineAntibacterial therapy in COVID-19  patients - an evidence based guideline
Antibacterial therapy in COVID-19 patients - an evidence based guideline
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
 
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
Lower respiratory disorders (pneumonia & tuberculosis,pertussis,influenza)- d...
 
lrd-200923144733.pdf
lrd-200923144733.pdflrd-200923144733.pdf
lrd-200923144733.pdf
 
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptxWORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
WORLD TUBERCULOSIS DAY MARCH 24 2021.pptx
 
Vaccine preventable diseases
Vaccine preventable diseasesVaccine preventable diseases
Vaccine preventable diseases
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
 
ROJOSON-PEP-TALK: Safety Program Against COVID19 (May 15, 2021)
ROJOSON-PEP-TALK: Safety Program Against COVID19 (May 15, 2021)ROJOSON-PEP-TALK: Safety Program Against COVID19 (May 15, 2021)
ROJOSON-PEP-TALK: Safety Program Against COVID19 (May 15, 2021)
 
Flu Vaccine
Flu VaccineFlu Vaccine
Flu Vaccine
 
Influenza - History, Vaccination, and Public Health
Influenza - History, Vaccination, and Public HealthInfluenza - History, Vaccination, and Public Health
Influenza - History, Vaccination, and Public Health
 
Pneumonia in children
Pneumonia in children Pneumonia in children
Pneumonia in children
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
The national flu immunisation programme 2017/18 - training for professionals
The national flu immunisation programme 2017/18 - training for professionalsThe national flu immunisation programme 2017/18 - training for professionals
The national flu immunisation programme 2017/18 - training for professionals
 
Pneumonia and its causes sign symptome treatment
Pneumonia and its causes sign symptome treatmentPneumonia and its causes sign symptome treatment
Pneumonia and its causes sign symptome treatment
 
Pneumonia in children
Pneumonia in childrenPneumonia in children
Pneumonia in children
 
Corona
CoronaCorona
Corona
 
Epidemiology of tuberculosis... 98754328
Epidemiology of tuberculosis... 98754328Epidemiology of tuberculosis... 98754328
Epidemiology of tuberculosis... 98754328
 

More from Joisy Aloor

DRUG INDUCED THYROID PROBLEMS
DRUG INDUCED THYROID PROBLEMS DRUG INDUCED THYROID PROBLEMS
DRUG INDUCED THYROID PROBLEMS
Joisy Aloor
 
Intracerebral Hemorrhage - Classification, Clinical symptoms, Diagnostics
Intracerebral Hemorrhage - Classification, Clinical symptoms, DiagnosticsIntracerebral Hemorrhage - Classification, Clinical symptoms, Diagnostics
Intracerebral Hemorrhage - Classification, Clinical symptoms, Diagnostics
Joisy Aloor
 
Churg -Strauss syndrome
Churg -Strauss syndromeChurg -Strauss syndrome
Churg -Strauss syndrome
Joisy Aloor
 
Vascular Diseases of the Bowel
Vascular Diseases of the Bowel  Vascular Diseases of the Bowel
Vascular Diseases of the Bowel
Joisy Aloor
 
Broken heart syndrome. Diagnostics
Broken heart syndrome. DiagnosticsBroken heart syndrome. Diagnostics
Broken heart syndrome. Diagnostics
Joisy Aloor
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
Joisy Aloor
 
Assessing Radial Pulse
Assessing Radial PulseAssessing Radial Pulse
Assessing Radial Pulse
Joisy Aloor
 
Lumbar Puncture
Lumbar Puncture Lumbar Puncture
Lumbar Puncture
Joisy Aloor
 
Cardiomyopathy joisy aloor.pptx
Cardiomyopathy joisy aloor.pptxCardiomyopathy joisy aloor.pptx
Cardiomyopathy joisy aloor.pptx
Joisy Aloor
 
Hypertrophic Cardiomyopathy
Hypertrophic CardiomyopathyHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
Joisy Aloor
 

More from Joisy Aloor (10)

DRUG INDUCED THYROID PROBLEMS
DRUG INDUCED THYROID PROBLEMS DRUG INDUCED THYROID PROBLEMS
DRUG INDUCED THYROID PROBLEMS
 
Intracerebral Hemorrhage - Classification, Clinical symptoms, Diagnostics
Intracerebral Hemorrhage - Classification, Clinical symptoms, DiagnosticsIntracerebral Hemorrhage - Classification, Clinical symptoms, Diagnostics
Intracerebral Hemorrhage - Classification, Clinical symptoms, Diagnostics
 
Churg -Strauss syndrome
Churg -Strauss syndromeChurg -Strauss syndrome
Churg -Strauss syndrome
 
Vascular Diseases of the Bowel
Vascular Diseases of the Bowel  Vascular Diseases of the Bowel
Vascular Diseases of the Bowel
 
Broken heart syndrome. Diagnostics
Broken heart syndrome. DiagnosticsBroken heart syndrome. Diagnostics
Broken heart syndrome. Diagnostics
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Assessing Radial Pulse
Assessing Radial PulseAssessing Radial Pulse
Assessing Radial Pulse
 
Lumbar Puncture
Lumbar Puncture Lumbar Puncture
Lumbar Puncture
 
Cardiomyopathy joisy aloor.pptx
Cardiomyopathy joisy aloor.pptxCardiomyopathy joisy aloor.pptx
Cardiomyopathy joisy aloor.pptx
 
Hypertrophic Cardiomyopathy
Hypertrophic CardiomyopathyHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
 

Recently uploaded

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 

Recently uploaded (20)

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 

Prophylactics of Pneumonia

  • 2. ACCORDING TO WHO • Pneumonia accounts for 15% of all deaths of children under 5 years old, killing 808 694 children in 2017. • Pneumonia can be caused by viruses, bacteria, or fungi. • Pneumonia can be prevented by immunization, adequate nutrition, and by addressing environmental factors. • Pneumonia caused by bacteria can be treated with antibiotics, but only one third of children with pneumonia receive the antibiotics they need.
  • 3. EPIDEMIOLOGY • Pneumonia is a common illness affecting approximately 450 million people a year and occurring in all parts of the world. It is a major cause of death among all age groups resulting in 4 million deaths (7% of the world's total death) yearly. • Rates are greatest in children less than five, and adults older than 75 years. It occurs about five times more frequently in the developing world than in the developed world. Viral pneumonia accounts for about 200 million cases. In the United States, as of 2009, pneumonia is the 8th leading cause of death.
  • 4.
  • 5.
  • 6. TREATMENT • Pneumonia should be treated with antibiotics. The antibiotic of choice is amoxicillin dispersible tablets. Most cases of pneumonia require oral antibiotics, which are often prescribed at a health centre. • These cases can also be diagnosed and treated with inexpensive oral antibiotics at the community level by trained community health workers. Hospitalization is recommended only for severe cases of pneumonia.
  • 7. PREVENTION • Preventing pneumonia in children is an essential component of a strategy to reduce child mortality. Immunization against Hib, pneumococcus, measles and whooping cough (pertussis) is the most effective way to prevent pneumonia. • Adequate nutrition is key to improving children's natural defenses, starting with exclusive breastfeeding for the first 6 months of life. In addition to being effective in preventing pneumonia, it also helps to reduce the length of the illness if a child does become ill.
  • 8. • Addressing environmental factors such as indoor air pollution (by providing affordable clean indoor stoves, for example) and encouraging good hygiene in crowded homes also reduces the number of children who fall ill with pneumonia. • In children infected with HIV, the antibiotic cotrimoxazole is given daily to decrease the risk of contracting pneumonia.
  • 9. PREVENTION BY WHO The WHO and UNICEF integrated Global action plan for pneumonia and diarrhoea (GAPPD) aims to accelerate pneumonia control with a combination of interventions to protect, prevent, and treat pneumonia in children with actions to: • Protect children from pneumonia including promoting exclusive breastfeeding and adequate complementary feeding;
  • 10. • Prevent pneumonia with vaccinations, hand washing with soap, reducing household air pollution, HIV prevention and cotrimoxazole prophylaxis for HIV-infected and exposed children. • Treat pneumonia focusing on making sure that every sick child has access to the right kind of care -- either from a community-based health worker, or in a health facility if the disease is severe -- and can get the antibiotics and oxygen they need to get well.
  • 11. • A number of countries including Bangladesh, India, Kenya, Uganda and Zambia have developed district, state and national plans to intensify actions for the control of pneumonia. • Many more have integrated pneumonia specific action into their national child health and child survival strategies. For many countries the post Millenium Development Goal agenda has explicitly included ending pneumonia deaths as a priority action.
  • 12. • Prevention includes vaccination, environmental measures and appropriate treatment of other health problems.[19] It is believed that, if appropriate preventive measures were instituted globally, mortality among children could be reduced by 400,000; and, if proper treatment were universally available, childhood deaths could be decreased by another 600,000.
  • 13. VACCINATION • Vaccination prevents against certain bacterial and viral pneumonias both in children and adults. Influenza vaccines are modestly effective at preventing symptoms of influenza. • The Center for Disease Control and Prevention (CDC) recommends yearly influenza vaccination for every person 6 months and older. Immunizing health care workers decreases the risk of viral pneumonia among their people.
  • 14. • Vaccinations against Haemophilus influenzae and Streptococcus pneumoniae have good evidence to support their use. There is strong evidence for vaccinating children under the age of 2 against Streptococcus pneumoniae (pneumococcal conjugate vaccine). • Vaccinating children against Streptococcus pneumoniae has led to a decreased rate of these infections in adults, because many adults acquire infections from children.
  • 15.
  • 16. PCV13 • The pneumococcal conjugate vaccine prevents against 13 kinds of bacteria that cause serious infections in children and adults. • PCV13 is part of the standard vaccination protocol for babies and is administered by a pediatrician.
  • 17. • In babies, it’s given as a three- or four-dose series, beginning when they’re 2 months old. The final dose is given to babies by 15 months. • In adults aged 65 and older, PCV13 is given as a one-time injection. Your doctor may recommend revaccination in 5 to 10 years.
  • 18. PPSV23 • Pneumococcal polysaccharide vaccine is a one- dose vaccine that protects against 23 kinds of bacteria. It’s not recommended for children. • PPSV23 is recommended for adults over age 65 who’ve already received the PCV13 vaccine. This typically occurs around one year later.
  • 19. • People aged 19 to 64 who smoke or have conditions that increase their risk for pneumonia should also get this vaccine. • People who receive PPSV23 at age 65 generally don’t require revaccination at a later date.
  • 20.
  • 21. • The pneumococcal vaccine has been shown to reduce the risk of community acquired pneumonia in people with chronic obstructive pulmonary disease, but does not reduce mortality or the risk of hospitalization for people with this condition. • People with COPD are suggested to have a pneumococcal vaccination. Other vaccines for which there is support for a protective effect against pneumonia include pertussis, varicella, and measles.
  • 22. • Certain people should not get the pneumonia vaccine. They include: • people who are allergic to the vaccine or any ingredient in it • people who had an allergic reaction to PCV7, a former version of the pneumonia vaccine • women who are pregnant • people who have a severe cold, flu, or other illness
  • 23. • Both pneumonia vaccines may have some side effects. These may include: • redness or swelling at the injection site • muscle aches • fever • chills
  • 24. • living in a hospice or institutionalized setting • using a ventilator • frequent hospitalizations • a weakened immune system • a progressive lung disease, such as COPD • asthma • heart disease • smoking cigarettes
  • 25. • People at risk for aspiration pneumonia include those who: • overuse alcohol or recreational drugs • have medical issues affecting their gag reflex, such as a brain injury or trouble swallowing • are recovering from surgical procedures that required anesthesia
  • 26. • Tips for avoiding postoperative pneumonia (pneumonia after surgery) include: • deep breathing and coughing exercises, which your doctor or nurse will walk you through • keeping your hands clean • keeping your head elevated • oral hygiene, which includes an antiseptic such as chlorhexidine • sitting as much as possible, and walking as soon as you are able
  • 27. OTHERS • Smoking cessation and reducing indoor air pollution, such as that from cooking indoors with wood or dung, are both recommended. Smoking appears to be the single biggest risk factor for pneumococcal pneumonia in otherwise-healthy adults. • Hand hygiene and coughing into one's sleeve may also be effective preventative measures. Wearing surgical masks by the sick may also prevent illness.
  • 28. • Appropriately treating underlying illnesses (such as HIV/AIDS, diabetes mellitus, and malnutrition) can decrease the risk of pneumonia. • In children less than 6 months of age, exclusive breast feeding reduces both the risk and severity of disease.
  • 29. • Testing pregnant women for Group B Streptococcus and Chlamydia trachomatis, and administering antibiotic treatment, if needed, reduces rates of pneumonia in infants. • Zinc supplementation in children 2 months to five years old appears to reduce rates of pneumonia.
  • 30.